FR2800614B1 - Composition pour le traitement des infections des voies respiratoires - Google Patents

Composition pour le traitement des infections des voies respiratoires

Info

Publication number
FR2800614B1
FR2800614B1 FR9914102A FR9914102A FR2800614B1 FR 2800614 B1 FR2800614 B1 FR 2800614B1 FR 9914102 A FR9914102 A FR 9914102A FR 9914102 A FR9914102 A FR 9914102A FR 2800614 B1 FR2800614 B1 FR 2800614B1
Authority
FR
France
Prior art keywords
treatment
composition
respiratory infections
infections
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9914102A
Other languages
English (en)
Other versions
FR2800614A1 (fr
Inventor
Jean Chatillon
Paul Ghislain Coupan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoire Top Pharm SARL
Original Assignee
Laboratoire Top Pharm SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Top Pharm SARL filed Critical Laboratoire Top Pharm SARL
Priority to FR9914102A priority Critical patent/FR2800614B1/fr
Priority to AU16467/01A priority patent/AU1646701A/en
Priority to PCT/FR2000/003114 priority patent/WO2001034182A2/fr
Publication of FR2800614A1 publication Critical patent/FR2800614A1/fr
Application granted granted Critical
Publication of FR2800614B1 publication Critical patent/FR2800614B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/47Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
FR9914102A 1999-11-10 1999-11-10 Composition pour le traitement des infections des voies respiratoires Expired - Lifetime FR2800614B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9914102A FR2800614B1 (fr) 1999-11-10 1999-11-10 Composition pour le traitement des infections des voies respiratoires
AU16467/01A AU1646701A (en) 1999-11-10 2000-11-09 Composition for treating respiratory tract infections
PCT/FR2000/003114 WO2001034182A2 (fr) 1999-11-10 2000-11-09 Composition pour le traitement des infections des voies respiratoires contenant le menthol, l'eucalyptol et une alpha-amylase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914102A FR2800614B1 (fr) 1999-11-10 1999-11-10 Composition pour le traitement des infections des voies respiratoires

Publications (2)

Publication Number Publication Date
FR2800614A1 FR2800614A1 (fr) 2001-05-11
FR2800614B1 true FR2800614B1 (fr) 2002-01-04

Family

ID=9551940

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9914102A Expired - Lifetime FR2800614B1 (fr) 1999-11-10 1999-11-10 Composition pour le traitement des infections des voies respiratoires

Country Status (3)

Country Link
AU (1) AU1646701A (fr)
FR (1) FR2800614B1 (fr)
WO (1) WO2001034182A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827776B1 (fr) * 2001-07-25 2005-09-30 Top Pharm Lab Composition comprenant un anti-inflammatoire enzymatique et un mucolytique
DE102006032233A1 (de) * 2006-07-12 2008-01-17 Ewabo Chemikalien Gmbh & Co. Kg Eukalyptol und Menthol enthaltende Zubereitung
FR2927256B1 (fr) * 2008-02-13 2010-05-14 Top Pharm Lab Composition pour le traitement des affections inflammatoires des voies respiratoires a base d'une alfa-amylase et d'un anesthesique local et son procede de preparation
WO2010078392A2 (fr) * 2008-12-31 2010-07-08 Novozymes North America, Inc. Procédés de production de produits de fermentation
WO2019175782A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comportant des souches bactériennes et utilisation de celles-ci dans la surveillance de micro-organismes pathogènes
WO2019175777A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et leur utilisation pour lutter contre des micro-organismes pathogènes
WO2019175780A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et utilisation correspondante pour lutter contre des micro-organismes pathogènes
WO2019175783A1 (fr) 2018-03-12 2019-09-19 Better Air International Limited Compositions comprenant des souches bactériennes et leur utilisation dans la régulation de micro-organismes pathogènes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740368A (en) * 1985-12-11 1988-04-26 Plevy Donald J Amylase containing breath cleansing confection

Also Published As

Publication number Publication date
AU1646701A (en) 2001-06-06
FR2800614A1 (fr) 2001-05-11
WO2001034182A2 (fr) 2001-05-17
WO2001034182A3 (fr) 2002-04-04

Similar Documents

Publication Publication Date Title
PT956858E (pt) Composicoes farmaceuticas contendo lactobacilos para o tratamento de infeccoes vaginais
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
GB0125222D0 (en) Composition for the treatment of microbial infections
FR07C0046I2 (fr) Beta-l-2'-desoxy-nucleosides pour le traitement de l'hepatite b
MA25823A1 (fr) Compositions pour le traitement de l'eau.
DZ1877A1 (fr) Forme posologiques d'azithromycine pour le traitement d'infection microbiennes.
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
MA27374A1 (fr) Ester de 2'-c-methyl-3'-o-l-valine et de ribofuranosyl cytidine pour le traitement des infections des flaviviridae
NO20055010D0 (no) Preparater inneholdende laktulose for behandling av potavirusinfeksjoner
FR22C1033I1 (fr) Utilisation de dihydroimidazolones pour le traitement des chiens
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
MA25847A1 (fr) Composition pour le traitement du dysfonctionnement endothelial.
MA25411A1 (fr) Microorganismes attenues pour le traitement d'infection.
DZ3014A1 (fr) Médicaments pour le traitement de l'hypertension.
DE60105614D1 (de) Oxazinochinolone für die behandlung viraler infektionen
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires
MA25386A1 (fr) Formulation a delivrance controlee pour le traitement des copd
ATE253578T1 (de) Oxazinochinolone zur behandlung von viralen infektionen
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
FR2835851B1 (fr) Composition pour le traitement d'alliages de magnesium
MA26117A1 (fr) Nouveau compose pour le traitement de l'impuissance

Legal Events

Date Code Title Description
CD Change of name or company name

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

TP Transmission of property

Owner name: LABORATOIRE TOP-PHARMA, FR

Effective date: 20120118

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20